If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksReabold Resources Regulatory News (RBD)

Share Price Information for Reabold Resources (RBD)

Share Price is delayed by 15 minutes
Get Live Data
76.00    0.00 (0.00%)
Bid:
75.00
Ask:
77.00
Spread: 2.00 (2.667%)
Market Cap: £11.02m
RBD Live PriceLast checked at - London Stock Exchange

Intraday Reabold Resources Share Chart

Contract Gain

11 Apr 2006 07:30

Adventis Group PLC11 April 2006 For release Adventis Group plc ("Adventis") Contract Gain Adventis ("ATG/L"), the multimedia marketing and advertising agency, announcesthat Affiniti UK Ltd, its Bucks-based healthcare agency has been appointed bySanofi Pasteur MSD, an existing client, to work on a campaign for a new vaccinethat could protect the elderly against shingles. An attack of shingles can be extremely painful, with around a quarter ofsufferers going on to develop post herpetic neuralgia, an often debilitatingillness which can last for months or even years. In the UK, about 250,000 peoplesuffer from shingles each year, almost half of these being over 60 years old. Affiniti won this 3-way pitch with a strong strategic approach, which furtherextends their vaccine product portfolio. Commenting, Affiniti MD, Stuart Tennant, said: "Everyone in the agency isdelighted. We continue to build market share in the healthcare sector," whereas,Charles Phillpot, Adventis CEO said in his statement for the year ended 31December 2005: "Revenue by sector grew over that achieved in the previous year." - ENDS - Editor's NotesAdventis Group plc is an AIM listed, full service marketing and advertisingagency, providing services to the property, healthcare and financial servicesindustries.Through its six operating companies the company provides a complete range ofcommunication services, including corporate identity programmes, advertisingcampaigns, media planning & buying, literature, public relation, packaging,exhibitions, research and planning, interiors, signage and digital media.Adventis employs over 80 staff in London and the South East.www.adventis.co.uk In January 2005, Adventis acquired Affiniti (UK) Ltd, a specialised UKhealthcare advertising agency with clients such as Allergan, Sanofi Pasteur MSD,Chiron Vaccines, Eden Biopharm, Leo Pharma and Serono. The acquisition hasperformed very well in 2005 with a pre-tax profit of £247,000 and builds on thefoothold Adventis Group already had in this profitable market. Enquiries: Adventis Group plcCharles Phillpot, Chief Executive Officer 020 7034 4750 Affiniti (UK) LtdStuart Tennant, Managing Director 01494 775 213 Seymour PierceJohn Depasquale 020 7107 8000 Binns & Co PR Ltd 020 7786 9600Peter Binns 07768 392 582Annie Evangeli 07778 507 162 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
16th Aug 20189:13 amRNSParta Information Memorandum
13th Aug 20187:00 amRNSUpdate on Reabold California
2nd Aug 20181:08 pmRNSHolding(s) in Company
30th Jul 20187:00 amRNSUpdate on Reabold California
25th Jul 20188:22 amRNSUpdate on Colter and Wick Projects
11th Jul 20189:58 amRNSParta - Independent Evaluation Results
5th Jul 20185:09 pmRNSHolding(s) in Company
29th Jun 201812:56 pmRNSResult of GM, and Acquisition of Gaelic Resources
29th Jun 20187:00 amRNSAnnual Report and Financial Statements 2017
22nd Jun 20184:44 pmRNSGeneral Meeting
15th Jun 201810:10 amRNSCompany Presentation
14th Jun 20187:00 amRNSAcquisition of Gaelic Resources and Notice of GM
4th Jun 20187:00 amRNSCPR on Corallian owned Oulton Appraisal Project
30th May 201812:38 pmRNSFinal tranche of investment in Corallian Energy
29th May 20182:02 pmRNSHolding(s) in Company
23rd May 20183:56 pmRNSCorallian 30th Seaward Licensing Round Award
15th May 20187:00 amRNSUpdate on Colter and Wick Projects
3rd Apr 20185:03 pmRNSTotal Voting Rights
3rd Apr 20183:35 pmRNSHolding(s) in Company
28th Mar 20189:46 amRNSFirst tranche of investment in Danube Petroleum
27th Mar 20183:45 pmRNSHolding(s) in Company
22nd Mar 201812:49 pmRNSHolding(s) in Company
21st Mar 20185:13 pmRNSHolding(s) in Company
19th Mar 20181:13 pmRNSResult of General Meeting, Issue of Equity, TVR
14th Mar 20184:24 pmRNSIssue of Options
2nd Mar 20186:04 pmRNSPosting of Circular
1st Mar 201811:30 amRNSIncreased Investment in Corallian Energy
28th Feb 20185:11 pmRNSResult of the Placing
28th Feb 201811:26 amRNSConditional Accelerated Bookbuild
27th Feb 201812:30 pmRNSCompany Update regarding the P2235 "Wick" Licence
26th Feb 20181:24 pmRNSStatement re Press Comment
12th Feb 20189:49 amRNSIntention to increase Corallian Energy investment
24th Jan 20185:20 pmRNSHolding(s) in Company
16th Jan 201811:16 amRNSUpdate on UK oil and gas assets
4th Dec 20177:00 amRNSInvestment in Danube Petroleum Limited
14th Nov 20177:00 amRNSPresentation at Investor Evening
1st Nov 20177:00 amRNSInvestment in UK oil and gas assets
27th Oct 20174:19 pmRNSHolding in Company
27th Oct 20179:12 amRNSHolding(s) in Company
19th Oct 20175:48 pmRNSBoard appointments and Issue of Options
16th Oct 20175:29 pmRNSHolding(s) in Company
12th Oct 201712:26 pmRNSResult of General Meeting, Issue of Equity, TVR
9th Oct 20177:00 amRNSSenior Management Appointments
2nd Oct 20174:35 pmRNSProposed subscription to raise £1.76 million
25th Sep 20173:37 pmRNSHolding(s) in Company
22nd Sep 20177:00 amRNSNotice of GM
20th Sep 20177:00 amRNSPlacing to raise £3.96m, update on strategy, TVR
19th Sep 20175:16 pmRNSHalf-year Report
14th Sep 20177:00 amRNSStmnt re Share Price Movement
16th Aug 20171:02 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.